ஜான் வேன் புற்றுநோய் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜான் வேன் புற்றுநோய் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜான் வேன் புற்றுநோய் நிறுவனம் Today - Breaking & Trending Today

City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer


City of Hope initiates Phase 2 clinical trial to investigate if mushroom tablets could slow prostate cancer
City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, is now recruiting patients for a Phase 2 clinical trial to investigate whether pills containing white button mushroom extract could regulate the immune system, affecting prostate-specific antigen (PSA) levels to either remain stable or decline. Heightened levels of PSA in men may indicate the existence of prostate tumors.
Shiuan Chen, Ph.D., the Lester M. and Irene C. Finkelstein Chair in Biology, has been investigating the potential beneficial effects of white button mushroom (Agaricus bisporus) at City of Hope for about 20 years. His translational preclinical and clinical research has found that this bioactive food available in most supermarkets might prevent or slow the spread of prostate and breast cancers. The common fungus appears ....

United States , South Pasadena , Rancho Cucamonga , West Covina , Clayton Lau , Pauline Martin Collins , Shiuan Chen , Irenec Finkelstein , Emily Henderson , John Wayne Cancer Institute In Santa Monica , National Cancer , City Of Hope Prostate Cancer Program , John Wayne Cancer Institute , National Cancer Institute Funded , Martin Collins Family Chair , Prostate Cancer , Prostate Cancer , Androgen Deprivation Therapy , Clinical Trial , Immune System , Prostate Specific Antigen , ஒன்றுபட்டது மாநிலங்களில் , தெற்கு பசதென , ராஞ்சோ சுகமாக , மேற்கு கோவினா , களிமண் லாவ் ,

iCAD (ICAD) Q1 2021 Earnings Call Transcript


iCAD (ICAD) Q1 2021 Earnings Call Transcript
Motley Fool Transcribing
© The Motley Fool
Logo of jester cap with thought bubble.
iCAD (NASDAQ: ICAD)
You may begin.
Investor Relations
Thank you, Devon, and good afternoon, everyone. Thank you for participating in today s call. Joining me from iCAD are Michael Klein, chairman and chief executive officer; Stacey Stevens, president; and Scott Areglado, chief financial officer. Earlier this afternoon, iCAD announced financial results for the three months ended March 31, 2021.
Before we begin, I would like to caution that comments made during this conference call by management contain forward-looking statements, involve risks and uncertainties regarding the operations and future results of iCAD. I would also note that management may refer to certain non-GAAP financial measures. Management believes that these measures provide meaningful information for investors and reflects the way th ....

United States , North Carolina , South Carolina , South Korea , Dave Turkaly , Chris Pasquale Guggenheim , Charles Carter , Emily Conant , Kyle Mikson , Andrew Dsilvab Riley , Mike Klein , Kyle Mikson Cantor Fitzgerald , Chris Pasquale , Santosh Kesari , Asia Pacific , Marie Thibault , Andrew Dsilva , Michael Klein , John Simon , Jeremy Feffer , Scott Areglado , Stacey Stevens , Francois Brisebois , Stace Stevens , American College Of Radiology , European Congress ,